FACULTY:
Alice Gong, MD, is a professor and neonatologist at UT Health San Antonio and medical director for their PREMIERe Program.
OVERVIEW:
Pediatrics Now host Holly Wayment interviews Dr. Alice Gong about updated newborn screening guidelines, expanded blood tests (now 59–60), additions like lysosomal storage disorders and SMA, point-of-care screens (hearing and critical congenital heart disease), and newborn blood spot retention and consent policies.
The episode covers testing timelines, follow-up coordination between hospitals and pediatricians, counseling families about results, special considerations for premature or critically ill infants, and emerging genomic approaches.
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Speaker: Alice Gong, MD, has no financial relationships with ineligible companies to disclose.
The Pediatrics Now Podcast Planning Committee members: Steven Seidner, MD, and Holly Wayment have no financial relationships with ineligible companies to disclose.
The University of Texas at San Antonio and Steven Seidner, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas at San Antonio designates this live activity up to a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
1/7/2026
EXPIRATION DATE:
8/31/2028